相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Switching TNFα inhibitors: Patterns and determinants
Rosanne W. Meijboom et al.
PHARMACOLOGY RESEARCH & PERSPECTIVES (2021)
The impact of seropositivity on the effectiveness of biologic anti-rheumatic agents: results from a collaboration of 16 registries
Delphine S. Courvoisier et al.
RHEUMATOLOGY (2021)
Persistence on biologic DMARD monotherapy after achieving rheumatoid arthritis disease control on combination therapy: retrospective analysis of corrona registry data
Dimitrios A. Pappas et al.
RHEUMATOLOGY INTERNATIONAL (2021)
C-reactive protein and implications in rheumatoid arthritis and associated comorbidities
Janet E. Pope et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2021)
Healthcare Costs of Not Achieving Remission in Patients with Rheumatoid Arthritis in the United States: A Retrospective Cohort Study
Martin Bergman et al.
ADVANCES IN THERAPY (2021)
2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis
Liana Fraenkel et al.
ARTHRITIS CARE & RESEARCH (2021)
Obesity reduces the real-world effectiveness of cytokine-targeted but not cell-targeted disease-modifying agents in rheumatoid arthritis
Martin Schaefer et al.
RHEUMATOLOGY (2020)
Rheumatoid Arthritis: The Impact of Mental Health on Disease: A Narrative Review
May N. Lwin et al.
RHEUMATOLOGY AND THERAPY (2020)
Comparison of Machine Learning Methods With Traditional Models for Use of Administrative Claims With Electronic Medical Records to Predict Heart Failure Outcomes
Rishi J. Desai et al.
JAMA NETWORK OPEN (2020)
Validation of a Claims-Based Frailty Index Against Physical Performance and Adverse Health Outcomes in the Health and Retirement Study
Dae Hyun Kim et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2019)
Sex Differences in Response to TNF-Inhibiting Drugs in Patients With Spondyloarthropathies or Inflammatory Bowel Diseases
Bruno Lagana et al.
FRONTIERS IN PHARMACOLOGY (2019)
Factors associated with medication adherence in a longitudinal study of rheumatoid arthritis patients
Nasir Wabe et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2019)
The economic burden of switching targeted disease-modifying anti-rheumatic drugs among rheumatoid arthritis patients
Ahva Shahabi et al.
JOURNAL OF MEDICAL ECONOMICS (2019)
Gender differences in retention rate of tumor necrosis factor alpha inhibitor treatment in ankylosing spondylitis: a retrospective cohort study in daily practice
Tamara Rusman et al.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2018)
Medication nonadherence in Korean patients with rheumatoid arthritis: the importance of belief about medication and illness perception
Young Sun Suh et al.
KOREAN JOURNAL OF INTERNAL MEDICINE (2018)
Pathogenetic insights from the treatment of rheumatoid arthritis
Iain B. McInnes et al.
LANCET (2017)
Adaptation and Validation of the Combined Comorbidity Score for ICD-10-CM
Jenny W. Sun et al.
MEDICAL CARE (2017)
Prevalence of rheumatoid arthritis in the United States adult population in healthcare claims databases, 2004-2014
Theresa M. Hunter et al.
RHEUMATOLOGY INTERNATIONAL (2017)
Medication adherence and persistence over time with self-administered TNF-alpha inhibitors among young adult, middle-aged, and older patients with rheumatologic conditions
Gregory S. Calip et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2017)
Anticitrullinated protein antibodies: origin and role in the pathogenesis of rheumatoid arthritis
Bryant R. England et al.
CURRENT OPINION IN RHEUMATOLOGY (2017)
Treatment Persistence and Healthcare Costs Among Patients with Rheumatoid Arthritis Changing Biologics in the USA
Benjamin Chastek et al.
ADVANCES IN THERAPY (2017)
Treatment Persistence and Clinical Outcomes of Tumor Necrosis Factor Inhibitor Cycling or Switching to a New Mechanism of Action Therapy: Real-world Observational Study of Rheumatoid Arthritis Patients in the United States with Prior Tumor Necrosis Factor Inhibitor Therapy
Wenhui Wei et al.
ADVANCES IN THERAPY (2017)
Impact of obesity on the response to tumor necrosis factor inhibitors in axial spondyloarthritis
Raphael Micheroli et al.
ARTHRITIS RESEARCH & THERAPY (2017)
Real-world evaluation of TNF-inhibitor utilization in rheumatoid arthritis
J. Harnett et al.
JOURNAL OF MEDICAL ECONOMICS (2016)
The influence of obesity on response to tumour necrosis factor-α inhibitors in psoriatic arthritis: results from the DANBIO and ICEBIO registries
Pil Hojgaard et al.
RHEUMATOLOGY (2016)
Rates, factors, reasons, and economic impact associated with switching in rheumatoid arthritis patients newly initiated on biologic disease modifying anti-rheumatic drugs in an integrated healthcare system
Nazia Rashid et al.
JOURNAL OF MEDICAL ECONOMICS (2016)
Determinants of adherence to disease modifying anti-rheumatic drugs in White British and South Asian patients with rheumatoid arthritis: a cross sectional study
Kanta Kumar et al.
BMC MUSCULOSKELETAL DISORDERS (2015)
The influence of behavioural and psychological factors on medication adherence over time in rheumatoid arthritis patients: a study in the biologics era
Catharine Morgan et al.
RHEUMATOLOGY (2015)
Drug survival on TNF inhibitors in patients with rheumatoid arthritis comparison of adalimumab, etanercept and infliximab
M. Neovius et al.
ANNALS OF THE RHEUMATIC DISEASES (2015)
Use of Anti-Tumor Necrosis Factor Therapy: A Retrospective Study of Monotherapy and Adherence to Combination Therapy with Non-Biologic Disease-Modifying Anti-Rheumatic Drugs
Nicole M. Engel-Nitz et al.
RHEUMATOLOGY AND THERAPY (2015)
Adjustment of therapy in rheumatoid arthritis on the basis of achievement of stable low disease activity with adalimumab plus methotrexate or methotrexate alone: the randomised controlled OPTIMA trial
Josef S. Smolen et al.
LANCET (2014)
Switching of biologic disease modifying anti-rheumatic drugs in patients with rheumatoid arthritis in a real world setting
Brian Meissner et al.
JOURNAL OF MEDICAL ECONOMICS (2014)
Factors associated with adherence to pharmaceutical treatment for rheumatoid arthritis patients: A systematic review
Annelieke Pasma et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2013)
Changes in Use of Disease-Modifying Antirheumatic Drugs for Rheumatoid Arthritis in the United States During 1983-2009
Seoyoung C. Kim et al.
ARTHRITIS CARE & RESEARCH (2013)
Sex Differences in Response to Anti-Tumor Necrosis Factor Therapy in Early and Established Rheumatoid Arthritis - Results from the DANBIO Registry
Damini Jawaheer et al.
JOURNAL OF RHEUMATOLOGY (2012)
Systematic Review and Meta-Analysis of the Efficacy and Safety of Existing TNF Blocking Agents in Treatment of Rheumatoid Arthritis
Kalle J. Aaltonen et al.
PLOS ONE (2012)
Patients With Early Rheumatoid Arthritis Who Smoke Are Less Likely to Respond to Treatment With Methotrexate and Tumor Necrosis Factor Inhibitors Observations From the Epidemiological Investigation of Rheumatoid Arthritis and the Swedish Rheumatology Register Cohorts
Saedis Saevarsdottir et al.
ARTHRITIS AND RHEUMATISM (2011)
Measurement and Rates of Persistence With and Adherence to Biologics for Rheumatoid Arthritis: A Systematic Review
Marissa A. Blum et al.
CLINICAL THERAPEUTICS (2011)
A combined comorbidity score predicted mortality in elderly patients better than existing scores
Joshua J. Gagne et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2011)
Validation of rheumatoid arthritis diagnoses in health care utilization data
Seo Young Kim et al.
ARTHRITIS RESEARCH & THERAPY (2011)
Relationship between serum acute-phase proteins and high disease activity in patients with rheumatoid arthritis
B. Cylwik et al.
ADVANCES IN MEDICAL SCIENCES (2010)
Regularization Parameter Selections via Generalized Information Criterion
Yiyun Zhang et al.
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION (2010)
Levels of C-Reactive Protein Associated with High and Very High Cardiovascular Risk Are Prevalent in Patients with Rheumatoid Arthritis
Jonathan Graf et al.
PLOS ONE (2009)
Depression in RA patients treated with anti-TNF is common and under-recognized in the rheumatology clinic
Samantha L. Hider et al.
RHEUMATOLOGY (2009)
Do changes in prescription practice in patients with rheumatoid arthritis treated with biological agents affect treatment response and adherence to therapy? Results from the nationwide Danish DANBIO Registry
M. L. Hetland et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trial
Paul Emery et al.
LANCET (2008)
Estimates of the prevalence of arthritis and other rheumatic conditions in the United States
Charles G. Helmick et al.
ARTHRITIS AND RHEUMATISM (2008)
Impact of concomitant DMARD therapy on adherence to treatment with etanercept and infliximab in rheumatoid arthritis. Results from a six-year observational study in southern Sweden
Lars Erik Kristensen et al.
ARTHRITIS RESEARCH & THERAPY (2006)
Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial
L Klareskog et al.
LANCET (2004)
分享论文
